Note 4. Research, development and quality assurance
|
Group |
Parent Company |
||
|---|---|---|---|---|
|
|
|
|
|
|
2018 |
2019 |
2018 |
2019 |
Expenditure for |
|
|
|
|
Research and development |
–3,727 |
–3,872 |
–1,544 |
–1,655 |
Quality assurance |
–423 |
–475 |
–252 |
–269 |
Total |
–4,150 |
–4,347 |
–1,796 |
–1,924 |
of which expensed, total |
–3,958 |
–4,149 |
–1,744 |
–1,858 |
of which expensed relating to research and development |
–3,535 |
–3,674 |
–1,492 |
–1,588 |
Research and quality assurance expenditures are expensed as incurred. Expenditure for development is recognized as an intangible asset if it meets the criteria for recognition as an asset in the balance sheet.